“Our partnership with Boomi will enhance our capability to deliver integrated solutions to life sciences organizations,” Ole ...

MFA presents a snapshot of the 2025 Medicare Advantage market with insights about the leading companies vying for business in ...

Libby and Andrew Potter usually ignore the avalanche of Medicare Advantage ads that land in the mailbox at their home in ...

In short, the IRA has proven to be a colossal failure. Hundreds of billions have been diverted from American seniors, who ...

HR leaders can drive change to reduce the risks and hidden costs posed by legacy PBMs. Learn how to protect your organization ...

Novo Nordisk seeks to put a stop to semaglutide compounding, whereas the FDA agrees to allow compounding of tirzepatide, for ...

Recent changes to Medicare Part D are part of an ongoing effort to make prescription drugs more affordable and accessible.

Pharmaceutical group's survey examines prescription drug costs as the industry calls for more transparency from insurers and PBMs. Other health industry news looks at the False Claims Act, ...

In a significant recognition of excellence, the Pennsylvania Public School Employees’ Retirement System (PSERS) has been awarded a 4.5-star rating from the federal Centers for Medicare and ...

Fierce Healthcare reporters returned from Las Vegas on Wednesday after four days packed with meetings, interviews and ...

The next president will face decisions on drug price negotiations, enhanced subsidies for Affordable Care Act plans and ...

Trump has promised to “ rescind all unspent funds under the misnamed Inflation Reduction Act” and gut its climate ...